Glucose-lowering efficacy of Xultophy with low doses by FreeStyle Libre as continuous glucose monitoring (CGM)
International Medicine · 2021 · 3 (2) · 65
DOI: 10.5455/im.59761 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Medicine, 2021. Verfasst von Takafumi Kawata und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kawata, T., Bando, H., Kato, Y., Kato, Y., Kanazawa, S., Sueki, E., Kanagawa, H., Kawahito, A., Aihara, A., & Fujii, A. (2021). Glucose-lowering efficacy of Xultophy with low doses by FreeStyle Libre as continuous glucose monitoring (CGM). International Medicine, 3(2), 65. https://doi.org/10.5455/im.59761
Vancouver
Kawata T, Bando H, Kato Y, Kato Y, Kanazawa S, Sueki E, et al. Glucose-lowering efficacy of Xultophy with low doses by FreeStyle Libre as continuous glucose monitoring (CGM). International Medicine. 2021;3(2):65. doi:10.5455/im.59761
BibTeX
@article{Kawata2021,
author = {Kawata, Takafumi and Bando, Hiroshi and Kato, Yoshinobu and Kato, Yoshikane and Kanazawa, Setsuko and Sueki, Etsuko and Kanagawa, Hiroe and Kawahito, Atsuko and Aihara, Aya and Fujii, Ayako},
title = {Glucose-lowering efficacy of Xultophy with low doses by FreeStyle Libre as continuous glucose monitoring (CGM)},
journal = {International Medicine},
year = {2021},
volume = {3},
number = {2},
pages = {65},
doi = {10.5455/im.59761}
}
EUVIMED